LifeMD, Inc. to Participate in Upcoming Investor Conferences
November 18 2022 - 04:05PM
GlobeNewswire Inc.
LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth
company, today announced that LifeMD management will participate in
the following upcoming conferences:
BTIG Digital Health Forum
Date: |
Nov 21, 2022 |
Format: |
Presenting: Virtual Primary
Care and Health Services |
Time: |
1:00 PM EST |
Registration: |
Register here |
Piper Sandler 34th
Annual Healthcare Conference
Date: |
Nov 29-Dec 1, 2022 |
Format: |
Available for one-on-one
meetings Nov 29-Dec 1 |
RHK Capital 2022 Disruptive
Growth Conference
Date: |
Dec 5-6, 2022 |
Format: |
Presenting; available for
one-on-one meetings Dec 5-6 |
Time: |
To be announced |
Registration: |
Register here |
Links to the live presentations will
be available on the investor portion of the company’s website,
which can be found at https://ir.lifemd.com. A copy of the
replay will be available for 90 days.
About LifeMDLifeMD is a 50-state
direct-to-patient telehealth company with a portfolio of brands
that offer virtual primary care, diagnostics, and specialized
treatment for men’s and women’s health, allergy & asthma, and
dermatological conditions. By leveraging its proprietary technology
platform, 50-state affiliated medical group, and nationwide
mail-order pharmacy network, LifeMD is increasing access to
top-notch healthcare that is affordable to anyone. To learn more,
go to LifeMD.com.
Cautionary Note Regarding Forward Looking
StatementsThis news release includes forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended; Section 21E of the Securities Exchange Act of
1934, as amended; and the safe harbor provision of the U.S. Private
Securities Litigation Reform Act of 1995. Forward-looking
statements contained in this news release may be identified by the
use of words such as: “believe,” “expect,” “anticipate,” “project,”
“should,” “plan,” “will,” “may,” “intend,” “estimate,” predict,”
“continue,” and “potential,” or, in each case, their negative or
other variations or comparable terminology referencing future
periods. Examples of forward-looking statements include, but are
not limited to, statements regarding our financial outlook and
guidance, short and long-term business performance and operations,
future revenues and earnings, regulatory developments, legal events
or outcomes, ability to comply with complex and evolving
regulations, market conditions and trends, new or expanded products
and offerings, growth strategies, underlying assumptions, and the
effects of any of the foregoing on our future results of operations
or financial condition.
Forward-looking statements are not historical facts and are not
assurances of future performance. Rather, these statements are
based on our current expectations, beliefs, and assumptions
regarding future plans and strategies, projections, anticipated and
unanticipated events and trends, the economy, and other future
conditions, including the impact of any of the aforementioned on
our future business. As forward-looking statements relate to the
future, they are subject to inherent risk, uncertainties, and
changes in circumstances and assumptions that are difficult to
predict, including some of which are out of our control.
Consequently, our actual results, performance, and financial
condition may differ materially from those indicated in the
forward-looking statements. These risks and uncertainties include,
but are not limited to, “Risk Factors” identified in our filings
with the Securities and Exchange Commission, including, but not
limited to, our most recently filed Annual Report on Form 10-K,
Quarterly Reports on Form 10-Q, and any amendments thereto. Even if
our actual results, performance, or financial condition are
consistent with forward-looking statements contained in such
filings, they may not be indicative of our actual results,
performance, or financial condition in subsequent periods.
Any forward-looking statement made in the news release is based
on information currently available to us as of the date on which
this release is made. We undertake no obligation to update or
revise any forward-looking statement, whether as a result of new
information, future events, or otherwise, except as may be required
under applicable law or regulation.
Company Contact LifeMD, Inc. Marc Benathen,
CFOmarc@lifemd.com
LifeMD (NASDAQ:LFMD)
Historical Stock Chart
From Apr 2023 to May 2023
LifeMD (NASDAQ:LFMD)
Historical Stock Chart
From May 2022 to May 2023